TABLE 2

Effect of Treatment and Time on Inflammation

	Time after radiation
Parameter	2 mo	3 mo	4 mo
CD68
% of lesion
Section A
No radiotracer	76.76 ± 11.03	51.86 ± 20.65^*	38.28 ± 11.26^†
¹⁸F-FDG	77.25 ± 8.98	62.85 ± 12.24	42.50 ± 9.93^†^,^‡
^99mTc-rhAnnexin V-128	76.43 ± 13.29	54.80 ± 12.79	34.79 ± 5.37^†
Section B
No radiotracer	69.17 ± 10.51	55.89 ± 17.05	42.38 ± 14.46^†
¹⁸F-FDG	76.85 ± 11.63	66.24 ± 15.50^*	45.81 ± 8.60^†
^99mTc-rhAnnexin V-128	79.06 ± 11.97	51.04 ± 11.89^*	40.78 ± 11.37^†
Section C
No radiotracer	74.05 ± 8.31	53.93 ± 18.72	45.75 ± 14.04^†^,^‡
¹⁸F-FDG	68.44 ± 17.27	64.13 ± 14.49	53.42 ± 15.14^†^,^‡
^99mTc-rhAnnexin V-128	76.06 ± 14.48	58.53 ± 7.22	36.59 ± 10.30^†
Area (mm²)
Section A
No radiotracer	0.075 ± 0.017	0.135 ± 0.040^*	0.153 ± 0.053^†
¹⁸F-FDG	0.053 ± 0.022	0.170 ± 0.055^*	0.180 ± 0.032^†
^99mTc-rhAnnexin V-128	0.056 ± 0.037	0.110 ± 0.038	0.161 ± 0.026^‡
Section B
No radiotracer	0.053 ± 0.013	0.110 ± 0.032^*	0.146 ± 0.043^†
¹⁸F-FDG	0.035 ± 0.016	0.127 ± 0.042^*	0.162 ± 0.050^†
^99mTc-rhAnnexin V-128	0.052 ± 0.037	0.098 ± 0.045	0.139 ± 0.036^†
Section C
No radiotracer	0.032 ± 0.013	0.069 ± 0.026^*	0.124 ± 0.034^†
¹⁸F-FDG	0.018 ± 0.012	0.079 ± 0.034^*	0.134 ± 0.054^†^,^‡
^99mTc-rhAnnexin V-128	0.044 ± 0.031	0.077 ± 0.048	0.097 ± 0.022

↵* P < 0.01 (2 vs. 3 mo).
↵† P < 0.001 (2 vs. 4 mo).
↵‡ P < 0.001 (3 vs 4 mo).
Data are mean ± SD.